This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International […]
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US
FDA Approval of New Drugs One of Many Goals for Drug Manufacturers Read Post »
This article was originally published by James A Smith, Zeeshaan Arshad, Hannah Thomas, Andrew J Carr & David A Brindley
Evidence of insufficient quality of reporting in patent landscapes in the life sciences Read Post »
This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative
Indian pharmaceutical patent prosecution: The changing role of Section 3(d) Read Post »
This paper was originally published by Qiaolei Jiang and Chunjuan Luan in Globalization and Health 2018 14:92 under a Creative Commons Attribution
Patents filed since 1995 last for 20 years from the date of patent application filing. This is true for “utility”
Drug Patent Life: How Long Do Drug Patents Last? Read Post »
This article was originally published by Basavaraj S, Guru V. Betageri in Acta Pharmaceutica Sinica B Volume 4, Issue 1, February 2014, Pages
This paper was originally published by T. Joseph Mattingly, Joseph F. Levy, Julia F. Slejko, Nneka C. Onwudiwe, and Eleanor M.
This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613